Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alla Bulashevska

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Journal of Theoretical Biology|July 10, 2008
Using Bayesian multinomial classifier to predict whether a given protein sequence is intrinsically disorderedAlla Bulashevska, Roland Eils
BMC Bioinformatics|June 16, 2006
Predicting protein subcellular locations using hierarchical ensemble of Bayesian classifiers based on Markov chainsAlla Bulashevska, Roland Eils
BMC Bioinformatics|January 27, 2010
Bayesian statistical modelling of human protein interaction network incorporating protein disorder informationSvetlana Bulashevska, Alla Bulashevska, Roland Eils
Computational Biology and Chemistry|November 7, 2009
Prediction of small molecule binding property of protein domains with Bayesian classifiers based on Markov chainsAlla Bulashevska, Martin Stein, David Jackson, et al.
Journal of Clinical Immunology|March 24, 2023
Fecal Immunoglobulin Levels as a Modifier of the Gut Microbiome in Patients with Common Variable ImmunodeficiencyChristina Nöltner, Alla Bulashevska, Katrin Hübscher, et al.
Haematologica|March 1, 2013
Transcription factor nuclear factor erythroid-2 mediates expression of the cytokine interleukin 8, a known predictor of inferior outcome in patients with myeloproliferative neoplasmsJulius Wehrle, Thalia S Seeger, Sven Schwemmers, et al.
Cancer Immunology, Immunotherapy : CII|September 18, 2010
Control of the specificity of T cell-mediated anti-idiotype immunity by natural regulatory T cellsMax Warncke, Maike Buchner, Gudrun Thaller, et al.
Frontiers in Immunology|June 13, 2024
Artificial intelligence and neoantigens: paving the path for precision cancer immunotherapyAlla Bulashevska, Zsófia Nacsa, Franziska Lang, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 4, 2021
SAMHD1 in cancer: curse or cure?Kerstin Schott, Catharina Majer, Alla Bulashevska, et al.
Frontiers in Immunology|July 19, 2019
Corrigendum: Assessing the Functional Relevance of Variants in the <i>IKAROS Family Zinc Finger Protein 1</i> (<i>IKZF1</i>) in a Cohort of Patients With Primary ImmunodeficiencyZoya Eskandarian, Manfred Fliegauf, Alla Bulashevska, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Journal of Theoretical Biology|July 10, 2008
Using Bayesian multinomial classifier to predict whether a given protein sequence is intrinsically disorderedAlla Bulashevska, Roland Eils
BMC Bioinformatics|June 16, 2006
Predicting protein subcellular locations using hierarchical ensemble of Bayesian classifiers based on Markov chainsAlla Bulashevska, Roland Eils
BMC Bioinformatics|January 27, 2010
Bayesian statistical modelling of human protein interaction network incorporating protein disorder informationSvetlana Bulashevska, Alla Bulashevska, Roland Eils
Computational Biology and Chemistry|November 7, 2009
Prediction of small molecule binding property of protein domains with Bayesian classifiers based on Markov chainsAlla Bulashevska, Martin Stein, David Jackson, et al.
Journal of Clinical Immunology|March 24, 2023
Fecal Immunoglobulin Levels as a Modifier of the Gut Microbiome in Patients with Common Variable ImmunodeficiencyChristina Nöltner, Alla Bulashevska, Katrin Hübscher, et al.
Haematologica|March 1, 2013
Transcription factor nuclear factor erythroid-2 mediates expression of the cytokine interleukin 8, a known predictor of inferior outcome in patients with myeloproliferative neoplasmsJulius Wehrle, Thalia S Seeger, Sven Schwemmers, et al.
Cancer Immunology, Immunotherapy : CII|September 18, 2010
Control of the specificity of T cell-mediated anti-idiotype immunity by natural regulatory T cellsMax Warncke, Maike Buchner, Gudrun Thaller, et al.
Frontiers in Immunology|June 13, 2024
Artificial intelligence and neoantigens: paving the path for precision cancer immunotherapyAlla Bulashevska, Zsófia Nacsa, Franziska Lang, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 4, 2021
SAMHD1 in cancer: curse or cure?Kerstin Schott, Catharina Majer, Alla Bulashevska, et al.
Frontiers in Immunology|July 19, 2019
Corrigendum: Assessing the Functional Relevance of Variants in the <i>IKAROS Family Zinc Finger Protein 1</i> (<i>IKZF1</i>) in a Cohort of Patients With Primary ImmunodeficiencyZoya Eskandarian, Manfred Fliegauf, Alla Bulashevska, et al.
Pageof 3